Why Does Muscle Tone Change in Canavan Disease Over Time?
At a Glance
In severe early-onset Canavan disease, children may start with low muscle tone (hypotonia) and later develop stiffness, spasticity, or dystonia as brain white-matter injury disrupts movement pathways. Tone changes vary, and sudden worsening may have a treatable cause.
The transition from being “floppy” (hypotonia) to becoming stiff (often spasticity or dystonia) is a common pattern in severe, early-onset Canavan disease [1][2]. This shift happens because of how the disease progressively affects the brain’s communication pathways over time, rather than due to a problem originating in the muscles themselves [3]. However, Canavan disease varies widely—some children may have persistent low tone, mixed tone, or milder symptoms, and the timing of these changes is not the same for every child [4][2].
Understanding the Terminology
When discussing muscle tone, your care team may use specific terms to describe what your child is experiencing [2][5]:
- Hypotonia: Low muscle tone, often described as feeling “floppy” [1].
- Hypertonia: The broad medical term for increased muscle tone or stiffness [2].
- Spasticity: A specific type of stiffness where the brain has difficulty regulating automatic reflexes, so a quick stretch or movement causes the limb to catch or tighten [5].
- Dystonia: Involuntary, patterned muscle contractions that can cause twisting movements or abnormal postures [5].
- Contracture: A fixed loss of joint movement that can develop over time when a limb remains in a shortened position [2].
The Role of NAA and White Matter
Canavan disease is caused by the deficiency of an enzyme called aspartoacylase, which normally breaks down a brain chemical called N-acetylaspartic acid (NAA) [3]. Because the enzyme isn’t working properly, NAA accumulates in the brain [3][6].
This accumulation of NAA is strongly associated with ongoing injury to the brain’s white matter—the tissue that contains nerve fibers and connects different parts of the brain [3][7]. Canavan disease is a leukodystrophy involving abnormal white-matter development (dysmyelination) and spongy degeneration (vacuolar changes) [8][9]. While the exact mechanisms are complex and still being studied, this progressive damage disrupts how the brain sends signals to the body [10].
From Floppy to Stiff: How It Happens
In typical severe Canavan disease, early brain injury commonly causes central hypotonia [1]. This early low muscle tone contributes to head lag and delayed motor milestones, making infants feel “floppy” [11][5].
As the disease progresses and white matter injury worsens, the brain pathways that normally regulate voluntary movement and suppress reflexes become impaired [8][5]. The brain loses its ability to smoothly coordinate these signals. This upper-motor-neuron injury can lead to spasticity, where automatic stretch reflexes become exaggerated, or dystonia [2][5].
It is also important to know that sudden increases in stiffness are not always due to disease progression. Treatable issues like pain, constipation, a full bladder, infections, reflux, or poorly fitting equipment can temporarily worsen muscle tone and should be evaluated [5].
Managing Tone and Safety
Because stiffness can impact your child’s comfort, positioning, and daily care, management is highly individualized. A neurologist or rehabilitation team will assess what type of tone changes your child has [5]. Physical and occupational therapies, seating assessments, stretching, and sometimes orthotics (braces) can improve comfort and help reduce the risk of contractures [2].
Medications may be considered to help relax muscles, but they must be carefully monitored by your clinician because they can cause side effects such as sleepiness, weakness, or worsened swallowing and breathing [5].
Breathing and Swallowing Safety
Changes in muscle tone and underlying neurologic progression can affect the muscles used for swallowing and breathing [8]. Contact your care team if you notice [5]:
- Coughing or choking during or after feeds
- Wet or gurgly breathing or voice
- Prolonged or exhausting feeds
- Repeated chest infections
Seek urgent or emergency medical care if your child experiences severe breathing difficulty, pauses in breathing, a blue or gray skin color, or choking that does not resolve [5].
Common questions in this guide
Do children with Canavan disease commonly become stiff after being floppy?
Why can muscle tone change from hypotonia to spasticity in Canavan disease?
How are spasticity and dystonia different in a child with Canavan disease?
Could a sudden increase in stiffness have a treatable cause?
How can muscle stiffness be managed in Canavan disease?
Which swallowing or breathing changes require urgent medical help?
Related questions
Show more
Get notified when new evidence is published on Canavan disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
The natural history of Canavan disease: 23 new cases and comparison with patients from literature.
Bley A, Denecke J, Kohlschütter A, et al.
Orphanet journal of rare diseases 2021; (16(1)):227 doi:10.1186/s13023-020-01659-3.
PMID: 34011350 - 2
Canavan Disease: Clinical and Laboratory Profile from Southern Part of India.
Gowda VK, Bharathi NK, Bettaiah J, et al.
Annals of Indian Academy of Neurology 2021; (24(3)):347-350 doi:10.4103/aian.AIAN_386_20.
PMID: 34446995 - 3
The pathogenesis of, and pharmacological treatment for, Canavan disease.
Wei H, Moffett JR, Amanat M, et al.
Drug discovery today 2022; (27(9)):2467-2483 doi:10.1016/j.drudis.2022.05.019.
PMID: 35636725 - 4
Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity.
Mendes MI, Smith DE, Pop A, et al.
Human mutation 2017; (38(5)):524-531 doi:10.1002/humu.23181.
PMID: 28101991 - 5
[Clinical and genetic analysis of a child with Canavan disease due to compound heterozygous variants of ASPA gene].
Niu S, Ma Y, Lyu Y, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2024; (41(2)):225-229 doi:10.3760/cma.j.cn511374-20221031-00733.
PMID: 38311564 - 6
N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
Francis JS, Wojtas I, Markov V, et al.
Neurobiology of disease 2016; (96()):323-334 doi:10.1016/j.nbd.2016.10.001.
PMID: 27717881 - 7
Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.
Guo F, Bannerman P, Mills Ko E, et al.
Annals of neurology 2015; (77(5)):884-8 doi:10.1002/ana.24392.
PMID: 25712859 - 8
Cytotoxic edema and diffusion restriction as an early pathoradiologic marker in canavan disease: case report and review of the literature.
Merrill ST, Nelson GR, Longo N, Bonkowsky JL
Orphanet journal of rare diseases 2016; (11(1)):169 doi:10.1186/s13023-016-0549-1.
PMID: 27927234 - 9
Suppressing N-Acetyl-l-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan Leukodystrophy.
Sohn J, Bannerman P, Guo F, et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2017; (37(2)):413-421 doi:10.1523/JNEUROSCI.2013-16.2016.
PMID: 28077719 - 10
N-Acetylaspartate Synthase Deficiency Corrects the Myelin Phenotype in a Canavan Disease Mouse Model But Does Not Affect Survival Time.
Maier H, Wang-Eckhardt L, Hartmann D, et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2015; (35(43)):14501-16 doi:10.1523/JNEUROSCI.1056-15.2015.
PMID: 26511242 - 11
[Genetic analysis and prenatal diagnosis for a Chinese pedigree affected with Canavan disease].
Sun G, Zhu X, Hu S, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2022; (39(8)):859-863 doi:10.3760/cma.j.cn511374-20210612-00499.
PMID: 35929936
This page is for informational purposes only and does not constitute medical advice. A neurologist or rehabilitation team should assess your child’s tone and swallowing or breathing concerns; seek emergency care for severe breathing difficulty or choking that does not resolve.